|
Volumn 41, Issue 4, 2002, Pages 362-365
|
Does famotidine enhance tumor infiltrating lymphocytes in breast cancer? - Results of a randomized prospective pilot study
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
INFILTRATION;
PATIENT MONITORING;
SURGERY;
TUMORS;
IMMUNOMODULATORS;
ONCOLOGY;
FAMOTIDINE;
IMMUNOMODULATING AGENT;
ADULT;
ARTICLE;
BREAST CANCER;
CANCER GRADING;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
FOLLOW UP;
HUMAN;
HUMAN TISSUE;
IMMUNOMODULATION;
LYMPH NODE METASTASIS;
LYMPHOCYTIC INFILTRATION;
MENOPAUSE;
PILOT STUDY;
PREOPERATIVE CARE;
PRIORITY JOURNAL;
PROGNOSIS;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
TUMOR ASSOCIATED LEUKOCYTE;
ADENOCARCINOMA, MUCINOUS;
ADULT;
AGED;
BREAST NEOPLASMS;
CARCINOMA, LOBULAR;
CASE-CONTROL STUDIES;
FAMOTIDINE;
FEMALE;
HISTAMINE H2 ANTAGONISTS;
HUMANS;
LYMPH NODES;
LYMPHATIC METASTASIS;
LYMPHOCYTES, TUMOR-INFILTRATING;
MIDDLE AGED;
NEOPLASM STAGING;
PILOT PROJECTS;
PROSPECTIVE STUDIES;
T-LYMPHOCYTES;
|
EID: 0036353912
PISSN: 0284186X
EISSN: None
Source Type: Journal
DOI: 10.1080/028418602760169415 Document Type: Article |
Times cited : (23)
|
References (30)
|